Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole
NCT02552641 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2022-08-05
Summary
The purpose of the study is assess whether the various forms of triple regimen of administration of treatment of Helicobacter pylori (before meals (fasting), after meals, and any independent mealtime) influence the rate of eradication of this bacterium.
Conditions
- Helicobacter Pylori Infection
Interventions
- OTHER
-
Food effect
- DRUG
-
Esomeprazole
- DRUG
-
Amoxicillin
- DRUG
-
Clarythromycin
Sponsors & Collaborators
-
EMS
lead INDUSTRY
Principal Investigators
-
Decio Chinzon, Phd · University of Sao Paulo
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-02-29
- Completion
- 2016-09-30
Countries
- Brazil
Study Locations
More Related Trials
-
Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection
NCT00520949 ·Status: COMPLETED ·Phase: NA
-
Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial
NCT00403364 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection
NCT05176821 ·Status: UNKNOWN ·Phase: NA
-
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
NCT05742568 ·Status: COMPLETED ·Phase: PHASE4
-
10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
NCT02959255 ·Status: COMPLETED ·Phase: PHASE4
-
Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori
NCT01667575 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
NCT03726099 ·Status: UNKNOWN ·Phase: PHASE4
-
5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection
NCT01544517 ·Status: COMPLETED ·Phase: PHASE3
-
RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
NCT02092506 ·Status: COMPLETED ·Phase: PHASE4
-
Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
NCT00455806 ·Status: UNKNOWN ·Phase: PHASE3
-
Furazolidone Quadruple Regimen Eradicate H. Pylori Infection
NCT06823791 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
NCT02576236 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases
NCT02922699 ·Status: COMPLETED ·Phase: PHASE4
-
Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection
NCT06250634 ·Status: COMPLETED ·Phase: NA
-
Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
NCT01792700 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole
NCT06318104 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians
NCT06315478 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
NCT04991584 ·Status: UNKNOWN ·Phase: NA
-
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
NCT04678492 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT04558502 ·Status: UNKNOWN ·Phase: PHASE4
-
The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
NCT04810793 ·Status: COMPLETED
-
Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
NCT02249546 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection
NCT05100446 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection
NCT02045251 ·Status: WITHDRAWN ·Phase: PHASE4